from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3254/-

LFCtreatmentdescriptionclass of inhibitor

-2.054

Amikacinug/mL Amikacintranslation

-1.352

Cap5-10ug/mL Capreomycintranslation

-1.871

Rox10-50 ug/mL Roxithromycintranslation

0.007

SM2-5 ug/mL Streptomycintranslation

-2.168

Tet5-10 ug/mL Tetracyclinetranslation

-0.618

Rif0.2-5ug/mL Rifampicintranscription

-0.384

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.709

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.411

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.579

CPZ10-50 ug/mL Chlorpromazinerespiration

1.299

Clofazimine10-13 ug/mL Clofaziminerespiration

1.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.185

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.370

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.043

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.976

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.097

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.093

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.601

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.359

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.348

KCN5-20 ug/mL Potassium cyaniderespiration

-0.065

NaN30.2-2 mM Sodium aziderespiration

0.426

Nigericin50 uM Nigericinrespiration

-0.420

TRC10-150 ug/mL Triclosanrespiration

0.926

TRZ10-25 ug/mL Thioridazinerespiration

-0.418

Valinomycin0.5-10 uM Valinomycinrespiration

1.161

ZnSO42 mM ZnSO4respiration

0.369

menadione6-10 ug/mL Menadionerespiration

0.598

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.585

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.575

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.752

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.668

NRP_1Non-replicating persistence stage 1dosRassociated

0.591

Amp0.2mg/mL AmpicillincellWall

0.602

Cephalexin20-100 ug/mL CephalexincellWall

0.362

Cerulenin0.32-5 ug/mL CerulenincellWall

0.667

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.578

EMB10-20 ug/mL EthambutolcellWall

0.211

Eta12-40 ug/mL EthionamidecellWall

-0.089

INH0.2-0.4 ug/mL IsoniazidcellWall

0.180

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.292

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.421

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.454

BZA0.12 mg/mL BenzamidearomaticAmides

-0.963

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.739

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.570

H2O24 mM hydrogen peroxideDNAdamaging

0.252

Levo10 ug/mL LevofloxacinDNAdamaging

0.334

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.721

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.158

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.125

UVUV-irradiationDNAdamaging

0.328

ARP41-4 ug/mL Antitubercular compound ARP4?

0.670

Antimycin12.5-50 ug/mL Antimycin A?

0.915

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.482

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.009

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.479

PA8240.2-2 ug/mL PA-824?

-1.232

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.345

Verapamil50 uM Verapamil?

1.000

mercaptoethanol2 mM 2-Mercaptoethanol?

1.329

methoxatin10-20 ug/mL Methoxatin?